Hofmeister Robert
Chief Scientific Officer at TCR2 THERAPEUTICS INC.
- Sold, on record
- $884k
- Dollars the filings state
- Form 4 sales
- 2
- Latest Nov 12, 2020
- Form 144 notices
- 0
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- TCR2 THERAPEUTICS INC.Chief Scientific Officer
Sales by reason
0
Routine
0
Plan not stated
0
No plan
0
Unusual
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale TCR2 THERAPEUTICS INC.UnusualOct 29 2020
Sold 20,000 shares at $19.10 ($382k)
Hofmeister Robert, Chief Science Officer
Sold 34% of holdings ($1.1M position)38,850 shares leftFirst sale on recordFiling
- 2 Form 4 sale TCR2 THERAPEUTICS INC.UnusualNov 12 +14 days
Sold 20,000 shares at $25.10 ($502k)
Hofmeister Robert, Chief Scientific Officer
Sold 34% of holdings ($1.5M position)38,850 shares leftFiling
Every transaction
Loading transactions…
Sales and notices (2)
| Source | ||||||||
|---|---|---|---|---|---|---|---|---|
| Nov 12, 2020 | TCR2 THERAPEUTICS INC. | Chief Scientific Officer | Form 4 sale | 20,000 | $502k | 34.0% | Unusual | SEC |
| Oct 29, 2020 | TCR2 THERAPEUTICS INC. | Chief Science Officer | Form 4 sale | 20,000 | $382k | 34.0% | Unusual | SEC |